PRA International Experts to Chair BioPharma Asia Panels

Drug Development Strategies for South Korea and India

RALEIGH, North Carolina, March 29, 2011 - PRA International, a leading Clinical Research Organization, announces
that two of our operational experts will conduct country-focused roundtable
sessions at the 4th Annual BioPharma Asia Convention being held in Singapore
28-31 March 2011. PRA will also host an exhibit at booth A01.

Day two of the convention will feature interactive roundtables exploring
drug development concerns in six key Asian countries. PRA's Dr. Yooni Kim,
Senior Manager of Clinical Operations, will lead the South Korea roundtable,
while Dr. Pramod Kabra, Director of Clinical Operations, will conduct the
India session. Attendees will have the opportunity to exchange ideas with the
hosts and gain further insight into country-specific innovations, policies
and strategies.

Dr. Kim, based in PRA's Seoul office, has over 10 years of clinical
research experience with major pharmaceutical companies and as a researcher
at the Seoul National University Hospital Clinical Trial Center. She also
serves on the advisory task force at KFDA, South Korea's regulatory
authority.

Working from PRA's office in Mumbai, Dr. Kabra has nearly 15 years of
experience in the pharmaceutical and CRO industries, including clinical
practice, bioequivalence and Phase I - IV studies. He has coordinated and
monitored approximately 100 clinical studies across various therapeutic
areas.

Additional PRA representatives from our Clinical Operations and Business
Development groups will be available to discuss our capabilities in Asia and
successful approach to drug development. Since 2008, PRA has participated in
more than 115 studies in the region, and we have been strategically expanding
our presence there for more than a decade. PRA has offices in South Korea,
India, Taiwan, China and Hong Kong.

About PRA

PRA conducts clinical trials across all therapeutic areas in more than 80
countries and provides services in all phases of clinical development through
its 39 global offices.

PRA's therapeutic expertise, global reach and project experience combined
with its extensive local knowledge and differentiating philosophy-THE
PERSONAL ELEMENT- enable its project teams to deliver consistent and on-time
performance. This unique PRA philosophy recognizes that true client service
comes only from trained, empowered and dedicated employees who are encouraged
to be innovative and to use their personal commitment to accelerate the
development life cycle.

To learn more about PRA International, please visit
www.PRAinternational.com, email Endpoints@PRAintl.com or call our
Global Headquarters at +1-(919)-786-8200.

Roger Boutin, Director of Marketing of PRA International, Inc., +1-434-951-3924